|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09688 ZAI LAB
Nominal 
28.800 +0.300 (+1.053%) | 2024/12 - Final USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | (214,869) | (198,178) | (367,642) | (549,231) | (216,055) |
| Net Cash from / (used in) Investing Activities | (375,193) | (10,776) | 420,016 | 249,957 | (554,830) |
| Net Cash from / (used in) Financing Activities | 349,889 | (6,433) | (1,730) | 820,202 | 1,132,440 |
| Increase / (Decrease) in Cash & Cash Equivalents | (240,173) | (215,387) | 50,644 | 520,928 | 361,555 |
| Cash & Cash Equivalents at beginning of period | 791,264 | 1,009,273 | 964,903 | 442,859 | 76,442 |
| Effect of Foreign Exchange Rate Changes | (310) | (2,622) | (6,274) | 1,116 | 4,862 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 550,781 | 791,264 | 1,009,273 | 964,903 | 442,859 |
| Remarks: | Real time quote last updated: 03/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -257,103,000 |
| %Change | -23.166% |
| EPS / (LPS) | USD -0.260 |
| NBV Per Share ($) | USD 0.768 |